• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于评估孕产妇疫苗接种安全性的疫苗安全数据链基础设施增强措施。

Vaccine Safety Datalink infrastructure enhancements for evaluating the safety of maternal vaccination.

作者信息

Naleway Allison L, Crane Bradley, Irving Stephanie A, Bachman Don, Vesco Kimberly K, Daley Matthew F, Getahun Darios, Glenn Sungching C, Hambidge Simon J, Jackson Lisa A, Klein Nicola P, McCarthy Natalie L, McClure David L, Panagiotakopoulos Lakshmi, Panozzo Catherine A, Vazquez-Benitez Gabriela, Weintraub Eric S, Zerbo Ousseny, Kharbanda Elyse O

机构信息

Center for Health Research, Kaiser Permanente Northwest, 3800 N. Interstate Ave, Portland, OR 97227, USA.

Center for Health Research, Kaiser Permanente Northwest, Portland, OR, USA.

出版信息

Ther Adv Drug Saf. 2021 Jun 14;12:20420986211021233. doi: 10.1177/20420986211021233. eCollection 2021.

DOI:10.1177/20420986211021233
PMID:34178302
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8207278/
Abstract

BACKGROUND

Identifying pregnancy episodes and accurately estimating their beginning and end dates are imperative for observational maternal vaccine safety studies using electronic health record (EHR) data.

METHODS

We modified the Vaccine Safety Datalink (VSD) Pregnancy Episode Algorithm (PEA) to include both the International Classification of Disease, ninth revision (ICD-9 system) and ICD-10 diagnosis codes, incorporated additional gestational age data, and validated this enhanced algorithm with manual medical record review. We also developed the new Dynamic Pregnancy Algorithm (DPA) to identify pregnancy episodes in real time.

RESULTS

Around 75% of the pregnancy episodes identified by the enhanced VSD PEA were live births, 12% were spontaneous abortions (SABs), 10% were induced abortions (IABs), and 0.4% were stillbirths (SBs). Gestational age was identified for 99% of live births, 89% of SBs, 69% of SABs, and 42% of IABs. Agreement between the PEA-assigned and abstractor-identified pregnancy outcome and outcome date was 100% for live births, but was lower for pregnancy losses. When gestational age was available in the medical record, the agreement was higher for live births (97%), but lower for pregnancy losses (75%). The DPA demonstrated strong concordance with the PEA and identified pregnancy episodes ⩾6 months prior to the outcome date for 89% of live births.

CONCLUSION

The enhanced VSD PEA is a useful tool for identifying pregnancy episodes in EHR databases. The DPA improves the timeliness of pregnancy identification and can be used for near real-time maternal vaccine safety studies.

PLAIN LANGUAGE SUMMARY

It is important to monitor of the safety of vaccines after they have been approved and licensed by the Food and Drug Administration, especially among women vaccinated during pregnancy. The Vaccine Safety Datalink (VSD) monitors vaccine safety through observational studies within large databases of electronic medical records. Since 2012, VSD researchers have used an algorithm called the Pregnancy Episode Algorithm (PEA) to identify the medical records of women who have been pregnant. Researchers then use these medical records to study whether receiving a particular vaccine is linked to any negative outcomes for the woman or her child. The goal of this study was to update and enhance the PEA to include the full set of medical record diagnostic codes [both from the older International Classification of Disease, ninth revision (ICD-9 system) and the newer ICD-10 system] and to incorporate additional sources of data about gestational age. To ensure the validity of the PEA following these enhancements, we manually reviewed medical records and compared the results with the algorithm. We also developed a new algorithm, the Dynamic Pregnancy Algorithm (DPA), to identify women earlier in pregnancy, allowing us to conduct more timely vaccine safety assessments. The new version of the PEA identified 2,485,410 pregnancies in the VSD database. The enhanced algorithm more precisely estimated the beginning of pregnancies, especially those that did not result in live births, due to the new sources of gestational age data. Our new algorithm, the DPA, was successful at identifying pregnancies earlier in gestation than the PEA. The enhanced PEA and the new DPA will allow us to better evaluate the safety of current and future vaccinations administered during or around the time of pregnancy.

摘要

背景

对于利用电子健康记录(EHR)数据开展的观察性孕产妇疫苗安全性研究而言,识别妊娠事件并准确估计其开始和结束日期至关重要。

方法

我们对疫苗安全数据链(VSD)妊娠事件算法(PEA)进行了修改,纳入了国际疾病分类第九版(ICD - 9系统)和ICD - 10诊断代码,整合了更多的孕周数据,并通过人工病历审查对这一增强算法进行了验证。我们还开发了新的动态妊娠算法(DPA)以实时识别妊娠事件。

结果

增强后的VSD PEA识别出的妊娠事件中,约75%为活产,12%为自然流产(SAB),10%为人工流产(IAB),0.4%为死产(SB)。99%的活产、89%的死产、69%的自然流产和42%的人工流产确定了孕周。PEA指定的与提取人员确定的妊娠结局及结局日期之间的一致性,活产为100%,但妊娠丢失的一致性较低。当病历中有孕周信息时,活产的一致性更高(97%),但妊娠丢失的一致性较低(75%)。DPA与PEA显示出高度一致性,对于89%的活产,在结局日期前≥6个月识别出妊娠事件。

结论

增强后的VSD PEA是在EHR数据库中识别妊娠事件的有用工具。DPA提高了妊娠识别的及时性,可用于近乎实时的孕产妇疫苗安全性研究。

通俗易懂的总结

在疫苗获得美国食品药品监督管理局批准和许可后,监测其安全性非常重要,尤其是在孕期接种疫苗的女性中。疫苗安全数据链(VSD)通过在大型电子病历数据库中开展观察性研究来监测疫苗安全性。自2012年以来,VSD研究人员使用一种名为妊娠事件算法(PEA)的算法来识别怀孕女性的病历。研究人员随后利用这些病历研究接种特定疫苗是否与女性或其孩子的任何不良结局相关。本研究的目的是更新和增强PEA,纳入全套病历诊断代码[既有旧的国际疾病分类第九版(ICD - 9系统),也有更新的ICD - 10系统],并纳入有关孕周的其他数据来源。为确保这些增强措施后PEA的有效性,我们人工审查了病历并将结果与算法进行了比较。我们还开发了一种新算法,动态妊娠算法(DPA),以在妊娠早期识别女性,使我们能够进行更及时的疫苗安全性评估。PEA的新版本在VSD数据库中识别出2485410例妊娠。由于新的孕周数据来源,增强后的算法更精确地估计了妊娠开始时间,尤其是那些未导致活产的妊娠。我们的新算法DPA成功地比PEA更早地识别出妊娠期的妊娠。增强后的PEA和新的DPA将使我们能够更好地评估当前和未来在孕期或孕期前后接种疫苗的安全性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ce6/8207278/a8e3ea4f43f4/10.1177_20420986211021233-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ce6/8207278/84680bf06b13/10.1177_20420986211021233-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ce6/8207278/0567214f3b72/10.1177_20420986211021233-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ce6/8207278/a8e3ea4f43f4/10.1177_20420986211021233-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ce6/8207278/84680bf06b13/10.1177_20420986211021233-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ce6/8207278/0567214f3b72/10.1177_20420986211021233-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8ce6/8207278/a8e3ea4f43f4/10.1177_20420986211021233-fig3.jpg

相似文献

1
Vaccine Safety Datalink infrastructure enhancements for evaluating the safety of maternal vaccination.用于评估孕产妇疫苗接种安全性的疫苗安全数据链基础设施增强措施。
Ther Adv Drug Saf. 2021 Jun 14;12:20420986211021233. doi: 10.1177/20420986211021233. eCollection 2021.
2
Identifying pregnancy episodes, outcomes, and mother-infant pairs in the Vaccine Safety Datalink.在疫苗安全数据链中识别妊娠事件、结局和母婴对子。
Vaccine. 2013 Jun 12;31(27):2898-903. doi: 10.1016/j.vaccine.2013.03.069. Epub 2013 Apr 30.
3
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
4
Uptake and safety of hepatitis A vaccination during pregnancy: A Vaccine Safety Datalink study.妊娠期甲型肝炎疫苗接种的吸收和安全性:疫苗安全数据链接研究。
Vaccine. 2019 Oct 16;37(44):6648-6655. doi: 10.1016/j.vaccine.2019.09.043. Epub 2019 Sep 20.
5
Association of Inadvertent 9-Valent Human Papillomavirus Vaccine in Pregnancy With Spontaneous Abortion and Adverse Birth Outcomes.意外接种 9 价人乳头瘤病毒疫苗与自然流产和不良妊娠结局的相关性。
JAMA Netw Open. 2021 Apr 1;4(4):e214340. doi: 10.1001/jamanetworkopen.2021.4340.
6
Coronavirus Disease 2019 (COVID-19) Vaccination and Stillbirth in the Vaccine Safety Datalink.2019 年冠状病毒病(COVID-19)疫苗接种与疫苗安全数据链接中的死胎。
Obstet Gynecol. 2024 Aug 1;144(2):215-222. doi: 10.1097/AOG.0000000000005632. Epub 2024 Jun 6.
7
Evaluating the Association of Stillbirths After Maternal Vaccination in the Vaccine Safety Datalink.评估疫苗安全数据链接中母亲接种疫苗后死胎的关联性。
Obstet Gynecol. 2020 Dec;136(6):1086-1094. doi: 10.1097/AOG.0000000000004166.
8
Validating Claims-Based Algorithms Determining Pregnancy Outcomes and Gestational Age Using a Linked Claims-Electronic Medical Record Database.利用关联的索赔-电子病历数据库验证基于索赔的算法来确定妊娠结局和孕龄。
Drug Saf. 2021 Nov;44(11):1151-1164. doi: 10.1007/s40264-021-01113-8. Epub 2021 Sep 30.
9
Uptake and safety of Hepatitis B vaccination during pregnancy: A Vaccine Safety Datalink study.妊娠期接种乙型肝炎疫苗的吸收和安全性:疫苗安全数据链接研究。
Vaccine. 2018 Oct 1;36(41):6111-6116. doi: 10.1016/j.vaccine.2018.08.074. Epub 2018 Sep 5.
10
Receipt of COVID-19 Vaccine During Pregnancy and Preterm or Small-for-Gestational-Age at Birth - Eight Integrated Health Care Organizations, United States, December 15, 2020-July 22, 2021.妊娠期间接种 COVID-19 疫苗与出生时早产或小于胎龄儿的关系-美国 8 家综合医疗保健组织,2020 年 12 月 15 日-2021 年 7 月 22 日。
MMWR Morb Mortal Wkly Rep. 2022 Jan 7;71(1):26-30. doi: 10.15585/mmwr.mm7101e1.

引用本文的文献

1
Effectiveness of 2023-2024 seasonal influenza vaccine against influenza-associated emergency department and urgent care encounters among pregnant and non-pregnant women of reproductive age.2023 - 2024年季节性流感疫苗对育龄孕妇和非孕妇流感相关急诊科就诊及紧急护理的有效性。
Vaccine. 2025 Jul 13;62:127483. doi: 10.1016/j.vaccine.2025.127483.
2
Coronavirus Disease 2019 (COVID-19) Vaccination and Spontaneous Abortion.2019冠状病毒病(COVID-19)疫苗接种与自然流产
Obstet Gynecol. 2025 May 2;146(1):129-137. doi: 10.1097/AOG.0000000000005904.
3
Projecting maximum potential demand for nirsevimab to protect eligible US infants and young children against respiratory syncytial virus in the 2024/2025 season.

本文引用的文献

1
SARS-CoV-2 Infection Among Hospitalized Pregnant Women: Reasons for Admission and Pregnancy Characteristics - Eight U.S. Health Care Centers, March 1-May 30, 2020.2020 年 3 月 1 日至 5 月 30 日,美国 8 个医疗中心因 SARS-CoV-2 感染住院的孕妇:住院原因和妊娠特征。
MMWR Morb Mortal Wkly Rep. 2020 Sep 23;69(38):1355-1359. doi: 10.15585/mmwr.mm6938e2.
2
Management of Stillbirth: Obstetric Care Consensus No, 10.死产管理:产科护理共识 No.10。
Obstet Gynecol. 2020 Mar;135(3):e110-e132. doi: 10.1097/AOG.0000000000003719.
3
Uptake and safety of hepatitis A vaccination during pregnancy: A Vaccine Safety Datalink study.
预测2024/2025季节nirsevimab保护美国 eligible婴幼儿免受呼吸道合胞病毒感染的最大潜在需求。 (注:“eligible”此处结合语境暂译为“符合条件的”,但感觉该词在原文中表述不太准确,可能原文有误或有特定背景含义,若有更准确信息,翻译会更精准。)
Vaccine. 2025 Apr 19;53:127109. doi: 10.1016/j.vaccine.2025.127109. Epub 2025 Apr 11.
4
Strengths and limitations of non-survey-based data sources for assessing adult vaccination coverage in the United States.在美国,用于评估成人疫苗接种覆盖率的非基于调查的数据来源的优势与局限性。
Expert Rev Vaccines. 2025 Dec;24(1):230-241. doi: 10.1080/14760584.2025.2483719. Epub 2025 Mar 27.
5
Development of a Pregnancy Cohort in Commercial Insurance Claims Data: Evaluation of Deliveries Identified From Inpatient Versus Outpatient Claims.利用商业保险理赔数据建立妊娠队列:评估住院与门诊理赔中识别出的分娩情况
Pharmacoepidemiol Drug Saf. 2025 Mar;34(3):e70115. doi: 10.1002/pds.70115.
6
Vaccination During Pregnancy in the Vaccine Safety Datalink, 2002-2022.2002 - 2022年疫苗安全数据链中的孕期疫苗接种情况
Pediatr Infect Dis J. 2025 Feb 1;44(2S):S105-S107. doi: 10.1097/INF.0000000000004607. Epub 2025 Feb 14.
7
Maternal Respiratory Syncytial Virus Vaccination and Receipt of Respiratory Syncytial Virus Antibody (Nirsevimab) by Infants Aged <8 Months - United States, April 2024.母亲接种呼吸道合胞病毒疫苗和 8 月龄以下婴儿接种呼吸道合胞病毒抗体(Nirsevimab)-美国,2024 年 4 月。
MMWR Morb Mortal Wkly Rep. 2024 Sep 26;73(38):837-843. doi: 10.15585/mmwr.mm7338a2.
8
Trends in and characteristics of drug overdose morbidity among pregnant and postpartum individuals in California, 2010-2018.2010 - 2018年加利福尼亚州孕妇和产后女性药物过量发病率的趋势及特征
Am J Epidemiol. 2025 Feb 5;194(2):379-388. doi: 10.1093/aje/kwae177.
9
Attitudes Toward COVID-19 Vaccines Among Pregnant and Recently Pregnant Individuals.孕妇和近期孕妇对 COVID-19 疫苗的态度。
JAMA Netw Open. 2024 Apr 1;7(4):e245479. doi: 10.1001/jamanetworkopen.2024.5479.
10
Racial and ethnic disparities in influenza vaccination coverage among pregnant women in the United States: The contribution of vaccine-related attitudes.美国孕妇流感疫苗接种率的种族和民族差异:与疫苗相关的态度的贡献。
Prev Med. 2023 Dec;177:107751. doi: 10.1016/j.ypmed.2023.107751. Epub 2023 Nov 4.
妊娠期甲型肝炎疫苗接种的吸收和安全性:疫苗安全数据链接研究。
Vaccine. 2019 Oct 16;37(44):6648-6655. doi: 10.1016/j.vaccine.2019.09.043. Epub 2019 Sep 20.
4
Inactivated influenza vaccine and spontaneous abortion in the Vaccine Safety Datalink in 2012-13, 2013-14, and 2014-15.2012-13、2013-14 和 2014-15 年疫苗安全数据链接中的灭活流感疫苗与自然流产。
Vaccine. 2019 Oct 16;37(44):6673-6681. doi: 10.1016/j.vaccine.2019.09.035. Epub 2019 Sep 17.
5
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2019-20 Influenza Season.季节性流感疫苗预防和控制:免疫实践咨询委员会的建议 - 美国,2019-20 流感季。
MMWR Recomm Rep. 2019 Aug 23;68(3):1-21. doi: 10.15585/mmwr.rr6803a1.
6
How Clinical Practice Research Datalink data are used to support pharmacovigilance.临床实践研究数据链数据如何用于支持药物警戒。
Ther Adv Drug Saf. 2019 May 31;10:2042098619854010. doi: 10.1177/2042098619854010. eCollection 2019.
7
Safety of 9-valent human papillomavirus vaccine administration among pregnant women: Adverse event reports in the Vaccine Adverse Event Reporting System (VAERS), 2014-2017.九价人乳头瘤病毒疫苗在孕妇中的安全性:2014-2017 年疫苗不良事件报告系统(VAERS)中的不良事件报告。
Vaccine. 2019 Feb 21;37(9):1229-1234. doi: 10.1016/j.vaccine.2018.11.077. Epub 2019 Jan 16.
8
Uptake and safety of Hepatitis B vaccination during pregnancy: A Vaccine Safety Datalink study.妊娠期接种乙型肝炎疫苗的吸收和安全性:疫苗安全数据链接研究。
Vaccine. 2018 Oct 1;36(41):6111-6116. doi: 10.1016/j.vaccine.2018.08.074. Epub 2018 Sep 5.
9
Risk of Spontaneous Abortion After Inadvertent Human Papillomavirus Vaccination in Pregnancy.意外接种 HPV 疫苗后孕妇自发性流产的风险。
Obstet Gynecol. 2018 Jul;132(1):35-44. doi: 10.1097/AOG.0000000000002694.
10
Prevention of Pertussis, Tetanus, and Diphtheria with Vaccines in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP).预防百日咳、破伤风和白喉的疫苗在美国:免疫实践咨询委员会(ACIP)的建议。
MMWR Recomm Rep. 2018 Apr 27;67(2):1-44. doi: 10.15585/mmwr.rr6702a1.